A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors

Name: A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors
Published: 2008
License: Public Domain

GlaxoSmithKline · 2008

ClinicalTrials.gov · Datasets · License: Public Domain · 2008

Open Source ↗

breast cancer neoplasms pharmacodynamics pharmacokinetics

neoplasms, breast, solid tumors, cancer, neoplasms, ovarian, doxorubicin, epirubicin, anti-angiogenesis, pharmacodynamics, pazopanib (gw786034), pharmacokinetics, soft tissue, sarcoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 1031223
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.